MedPath

Implementing and Testing the Effectiveness of an Integrated Model of Care after Allogeneic SteM Cell TransplantatIon faciLitated by eHealth Technology (SMILe) — a RCT at the Medical Center–University of Freiburg

Not Applicable
Conditions
allogeneic stem-cell transplantation
Registration Number
DRKS00020347
Lead Sponsor
niversität Basel, Institut für Pflegewissenschaft
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

Scheduled allogeneic stem-cell transplantation at the University Hospital Freiburg, = 18 years, able to speak, read and write German, able to plan and perform self-management activities independently; WLAN or mobile data access , mental, physical and psychological abilities and health to provide a written informed consent about study participation and related data protection

Exclusion Criteria

Patients who do not fulfill the inclusion criteria. Patients with a second allogeneic stem-cell transplantation within the first year after the first stem-cell transplantation will be excluded.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total healthcare utilization costs in the first year after allogeneic stem-cell transplantation
Secondary Outcome Measures
NameTimeMethod
re-hospitalization rate, length of re-hospitalizations, rate of medication non-adherence, treatment burden, health-related quality of life, rate of Graft-versus-Host-Disease episodes, overall survival rate and re-hospitalization-free survival rate in the first year after allogeneic stem-cell transplantation.<br>The evaluation of implementation outcomes as acceptability, feasibility, adoptability and fidelity will be done also.
© Copyright 2025. All Rights Reserved by MedPath